Synthesis of novel derivatives of 4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole as potential HIV-1 NNRTIs. 2007

Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, No.44, Wenhuaxi Road, Jinan, 250012, PR China.

A series of 5-alkylthio (2a-d), 4-arylideneamino (3a-d) and 4-arylideneamino-5-alkylthio derivatives (4a-f) of 4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole (1) were synthesized by alkylation of the parent compound with alkyl halides and condensation with aldehydes, respectively. Sulfanyl dimers 5a-d and 4-iminomethyl dimer 6 were correspondingly prepared by reaction with alkane dibromides and 1,4-diformylbenzene. Mannich base 7 was also synthesized by aminomethylation of the 3-sulfanyltriazole 1 at the N1 position. The newly designed and synthesized substituted s-triazole derivatives were assayed for anti-HIV-1 activity by examination of their inhibition of HIV-1-induced cytopathogenicity in MT-4 cells and by determination of their inhibitory effect on HIV-1 reverse transcriptase. Compound 4e was found to be the most active inhibitor against HIV-1 replication in cell culture (EC50 = 12 microM) and against HIV-1 reverse transcriptase (IC50 = 43.5 microM), which provided a good lead for further optimization.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013438 Sulfhydryl Compounds Compounds containing the -SH radical. Mercaptan,Mercapto Compounds,Sulfhydryl Compound,Thiol,Thiols,Mercaptans,Compound, Sulfhydryl,Compounds, Mercapto,Compounds, Sulfhydryl
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
July 2007, Molecules (Basel, Switzerland),
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
April 2010, Journal of pharmacy & bioallied sciences,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
March 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
November 1981, Rinsho byori. The Japanese journal of clinical pathology,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
August 2016, Bioorganic & medicinal chemistry letters,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
February 2021, Molecular diversity,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
April 2018, Langmuir : the ACS journal of surfaces and colloids,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
November 2020, Bioorganic chemistry,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
January 1996, Acta poloniae pharmaceutica,
Jingde Wu, and Xinyong Liu, and Xianchao Cheng, and Yuan Cao, and Defeng Wang, and Zhong Li, and Wenfang Xu, and Christophe Pannecouque, and Myriam Witvrouw, and Erik De Clercq
October 2019, Bioorganic chemistry,
Copied contents to your clipboard!